review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/0014-4894(77)90095-9 |
P953 | full work available at URL | https://api.elsevier.com/content/article/PII:0014489477900959?httpAccept=text/plain |
https://api.elsevier.com/content/article/PII:0014489477900959?httpAccept=text/xml | ||
P698 | PubMed publication ID | 18362 |
P2093 | author name string | A. Zuckerman | |
P2860 | cites work | Journal of Parasitology | Q6295713 |
Clinical and Experimental Immunology | Q15716708 | ||
East African Medical Journal | Q15751001 | ||
Southeast Asian Journal of Tropical Medicine and Public Health | Q15754995 | ||
Israel Medical Association Journal | Q133979 | ||
Journal of the National Cancer Institute | Q400279 | ||
avian malaria | Q2663527 | ||
Bulletin of the World Health Organization | Q2928049 | ||
Journal of Immunology | Q3521441 | ||
The American Journal of Pathology | Q4744259 | ||
Enzyme typing of malaria parasites | Q67240422 | ||
Burkitt's lymphoma and malaria | Q69375847 | ||
Separation of malarial parasites according to age by density gradient centrifugation | Q70078831 | ||
Plasmodium berghei freed from host erythrocytes by a continuous-flow ultrasonic system | Q70445117 | ||
Isolated erythrocytic forms of Plasmodium berghei. An electron-microscopical study | Q71246911 | ||
Adoptive Transfer of Immunity to Plasmodium berghei | Q71266562 | ||
Enzyme variation in Plasmodium berghei | Q71527546 | ||
Acquired immunity toPlasmodium chabaudiin Swiss TO mice | Q71644750 | ||
Plasmodium berghei: Precipitins in rats infected with attenuated strain, made hyperimmune to virulent strain, or vaccinated with extract of virulent strain | Q71760849 | ||
Antigenic Structure of Plasmodium vinckei | Q76492568 | ||
Plasmodium berghei: Enhanced Protective Immunity after Vaccination of White Rats Born of Immune Mothers | Q81208955 | ||
Continuous temperature measurements during malaria infections | Q95781126 | ||
Separation of genetically distinct lines from a recently isolated strain of Plasmodium berghei yoelii | Q95787909 | ||
Clay G. Huff: with great esteem | Q95789700 | ||
Proceedings of the Helminthological Society of Washington | Q21385397 | ||
Bulletin of the New York Academy of Medicine | Q23929973 | ||
Tropical and Geographical Medicine | Q26842038 | ||
The British Journal of Experimental Pathology | Q26842212 | ||
Journal of Tropical Medicine and Hygiene | Q26842227 | ||
Serological malaria surveys in Nigeria | Q27486958 | ||
Archives roumaines de pathologie experimentales et de microbiologie | Q27709182 | ||
International review of tropical medicine | Q27711290 | ||
Journal of General Microbiology | Q27711489 | ||
Archives of pathology | Q27720882 | ||
A capillary tube agglutination test for malaria | Q30489459 | ||
AUTOIMMUNIZATION AND OTHER TYPES OF INDIRECT DAMAGE TO HOST CELLS AS FACTORS IN CERTAIN PROTOZOAN DISEASES. | Q33355137 | ||
THE ANTIGENIC ANALYSIS OF PLASMODIA. | Q34256304 | ||
The serology of malaria: recent applications | Q35543622 | ||
Alterations of red blood cell sodium transport during malarial infection | Q35569059 | ||
Influence of erythrocyte membrane components on malaria merozoite invasion | Q36272685 | ||
Helminthological Society of Washington | Q36318973 | ||
Plasmodium inui: Serologic relationships of Asian isolates | Q36539460 | ||
Antibody levels detected by the fluorescent antibody technique in mice infected with Plasmodium vinckei and P. chabaudi | Q36719427 | ||
The indirect fluorescent antibody test for the detection of occult malaria in blood donors | Q36720598 | ||
The antibody response to sporozoites of simian and human malaria parasites: its stage and species specificity and strain cross-reactivity | Q36786513 | ||
Immunization of man against sporozite-induced falciparum malaria | Q44157817 | ||
Genetic recombination in Plasmodium berghei | Q44157875 | ||
Increased nonspecific resstance to malaria produced by administration of killed Corynebacterium parvum | Q44164016 | ||
Resistance produced in rats and mice by exposure to irradiated Plasmodium berghei | Q44237339 | ||
Impairment of Antibody Response and Recovery in Malarial Rodents by Antilymphocyte Serum | Q44263595 | ||
Mass diagnostic test using Plasmodium falciparum and chimpanzee erythrocyte lysate | Q44401258 | ||
Persistence of Malaria Antibody in Tobago, West Indies, Following Eradication, as Measured by the Indirect Hemagglutination Test * | Q44556638 | ||
Absence of immunity between Trypanosoma musculi and intra-erythrocytic protozoa in mice | Q44617714 | ||
Plasmodium berghei: Nucleic acid agglutinating antibodies in rats | Q44676033 | ||
Malaria, anaemia and pregnancy | Q45014349 | ||
The course of simultaneously inoculated, concomitant infections with Plasmodium vinckei and Plasmodium berghei in white mice | Q45104074 | ||
Multiple modes of action of cyclophosphamide on plasmodial infections in rats | Q45204310 | ||
Experimental Malaria: Effects upon the Immune Response to Different Antigens | Q45302308 | ||
Depression of Immune Response to Moloney Leukaemia Virus by Malarial Infection | Q45816362 | ||
Preparation and use of malarial placenta antigen for immunodiffusion studies in a Nigerian population | Q46177544 | ||
Sero-epidemiological studies on population groups previously exposed to malaria | Q46665247 | ||
Letter: Mechanism of host specificity in malarial infection | Q46794084 | ||
Specificity of Immunoglobulin G in Rhesus Monkeys Infected with Schistosoma mansoni, Plasmodium knowlesi, and Trypanosoma brucei | Q47670450 | ||
Action of Malarial Antibody in vitro | Q47680023 | ||
Antiplasmodial precipitins demonstrated by double diffusion in agar gel in the serum of rats infected with Plasmodium berghei | Q47683298 | ||
Studies of splenomegaly in rodent malaria. II. The course of splenomegaly, IgM, IgG levels and IgG immunofluorescent antibody titre in mice after infection with Plasmodium berghei yoelii and-or Plasmodium chabaudi | Q47743694 | ||
Comparison of the Indirect-Fluorescent Antibody and Indirect-Hemagglutination Tests for Malarial Antibody * | Q47747426 | ||
Patterns of antibody and serum proteins in experimentally induced human malaria | Q47750628 | ||
Serological malaria survey in the Ethiopian highlands | Q47756710 | ||
Splenomegaly and Malaria in the Central Highlands of South Vietnam *,† | Q47769821 | ||
Natural and Acquired Antibodies to Plasmodium lophurae in Intact and Bursaless Chickens. II. Immunofluorescent Studies | Q47788739 | ||
Dynamics of thymidine incorporation by spleen cells from rats infected with Plasmodium berghei | Q47839083 | ||
Adoptive transfer of immunity to Plasmodium berghei by a population of immune rat spleen cells resistant to cyclophosphamide | Q47839459 | ||
Plasmodium berghei: I. Immunochemical properties of fractions of a soluble extract | Q47839660 | ||
Plasmodium berghei: II. Immunobiological properties of fractions of a soluble extract | Q47839673 | ||
Neutralizing antibody in rodent malaria | Q47845976 | ||
Antibody levels in mice infectedwith Plasmodium berghei yoelii | Q47932097 | ||
Plasmodium berghei infection in neonatallythymectomized hamsters | Q47932149 | ||
Precipitating antibodies and immunoglobulins in P. falciparum infections in The Gambia, West Africa | Q47932225 | ||
Immunization against Plasmodium knowlesi malaria | Q47932661 | ||
Soluble antigens in the blood of African patients with severe plasmodium falciparum malaria | Q47934104 | ||
Autoimmune disease and parasitic infections in Nigerians | Q47934197 | ||
Evidence for soluble immune complexes in the pathogenesis of the glomerulonephritis of quartan malaria | Q47934519 | ||
Antigens associated with Plasmodium falciparum infections in man. | Q47934742 | ||
Properties of protective malarial antibody | Q47934960 | ||
Burkitt lymphoma and malaria | Q47935139 | ||
Comparison of precipitation malarial antibodies produced by indigenous immune Gambians and an infected European. | Q47935345 | ||
The stability and fractionation of malarial antigens from the blood of Africans infected with Plasmodium falciparum | Q47935359 | ||
Isolation of blood-stage merozoites from Plasmodium knowlesi malaria | Q47935407 | ||
Enzyme variants in primate malaria parasites | Q47935811 | ||
A multi-species malaria antigen for use in the indirect fluorescent antibody test | Q47935873 | ||
Cytochrome oxidase activity in platelet-free preparations of Plasmodium knowlesi | Q47938142 | ||
The immunodepressive effect of a murine plasmodium and its interaction with murine oncogenic viruses | Q47938175 | ||
A merozoite vaccine effective against Plasmodium knowlesi malaria | Q47939749 | ||
Residual immunity following radical cure of Plasmodium berghei in intact and splenectomized voles (Microtus guentheri). | Q47939753 | ||
Antigenic variation and immunity to Plasmodium knowlesi: antibodies which induce antigenic variation and antibodies which destroy parasites | Q47940080 | ||
Chronic splenomegaly in Vietnam. I. Evidence for malarial etiology | Q47941838 | ||
Plasmodium berghei and Eperythrozoon coccoides: Antibody and immunoglobulin synthesis in germfree and and conventional mice simultaneously infected | Q47942881 | ||
Inactivity of rodent malaria anti-sporozoite antibodies against exoerythrocytic forms | Q47943048 | ||
Plasmodium vivax antigen for use in the indirect hemagglutination test for malaria | Q47943530 | ||
The direct antiglobulin test and immunoconglutinin titres in patients with malaria | Q47943830 | ||
A comparative account of the effects of betamethasone on mice infected with Plasmodium vinckei chabaudi and Plasmodium berghei yoelii | Q47943880 | ||
Some factors influencing the induction, maintenance and degree of maternally transmitted protective immunity to malaria (Plasmodium berghei) | Q47943899 | ||
Enzyme variation in Plasmodium falciparum in the Gambia | Q47944093 | ||
Demonstration of malarial antigens in the sera of Plasmodium berghei-infected mice | Q47946136 | ||
A comparison of malarial antigens from human and Aotus monkey blood infected with Plasmodium falciparum. | Q47946162 | ||
Experimental infection with Plasmodium falciparum in Aotus monkeys. I. Parasitologic, hematologic, and serum biochemical determinations | Q47946195 | ||
The Indirect Fluorescent Antibody Test for Malaria | Q47946544 | ||
Immunity to malaria and piroplasmosis in mice following low level infections with Anthemosoma garnhami (Piroplasmea: Dactylosomidae) | Q47946725 | ||
Babesia argentina, plasmodium vivax and P. falciparum: Antigenic cross-reactions | Q47946785 | ||
The effects of -radiation on Plasmodium knowlesi | Q47946900 | ||
IgM antibodies to red cells and autoimmune anemia in patients with malaria | Q47946935 | ||
Antibody Induced Variation in Malaria Parasites | Q47947088 | ||
Use of Stable Sensitized Cells in Indirect Microhemagglutination Test for Malaria * | Q47947256 | ||
Indirect hemagglutination test for malaria with lyophilized cells | Q47947502 | ||
Plasmodium gallinaceum: mechanisms of anemia in infected chickens | Q47947688 | ||
Erythrocyte destruction in Plasmodium falciparum malaria: an investigation of intravascular haemolysis | Q47951249 | ||
Malaria-antibody patterns as determined by the IFA test in U.S. servicemen after chemotherapy. | Q47951416 | ||
Antigenic changes during the life cycle ofPlasmodium falciparum | Q47951810 | ||
Removal of white blood cells from gametocyte-, schizont-, trophozoite- and ring stages of Plasmodium falciparum | Q47952635 | ||
Immunological studies on simian malaria parasites IV. Heterologous superinfection of monkeys with chronic Plasmodium knowlesi infections | Q47955018 | ||
Is there a malaria toxin? | Q47955050 | ||
Antigens and antibodies associated with Plasmodium falciparum infections in West Africa | Q47955986 | ||
Passive immunity in Plasmodium knowlesi malaria | Q47956049 | ||
Malarial S-antigens from man and owl monkey infected with Plasmodium falciparum | Q47956153 | ||
Centrifugal Elutriation for the Removal of Leukocytes from Malaria-Infected Monkey Blood | Q47956422 | ||
A rapid method for the complete removal of white cells from large batches of monkey blood infected with the trophozoite- and schizont-stages of Plasmodium knowlesi | Q47956504 | ||
Plasmodium berghei: adherence and phagocytosis by rat macrophages in vitro | Q47956985 | ||
Plasmodium: A resumé of the isolation of a vaccine fraction by the French pressure cell technique | Q47957007 | ||
Plasmodium berghei: Vaccination of mice against malaria with heat inactivated parasitized blood | Q47957015 | ||
Plasmodium berghei: Accelerated clearance of sporozoites from blood as part of immune-mechanism in mice | Q47957026 | ||
Concomitant toxoplasma and malaria in mice | Q47957471 | ||
Immunosuppression in rodent malaria. Effect upon recovery and antibody response. | Q47957995 | ||
Some Quantitative Aspects of the Adoptive Transfer of Immunity to Plasmodium berghei with Immune Spleen Cells | Q47958840 | ||
Transfer of Adoptive Immunity to Plasmodium berghei: A Comparison of Routes of Injection* | Q47958863 | ||
Plasmodium gallinaceum: Variation in susceptibility of dove erythrocyte | Q47959014 | ||
Acquired immunity to Plasmodium berghei yoelii in mice | Q47959347 | ||
The fluorescent antibody technique in the estimation of immunity in patients infected with Plasmodium malariae | Q47960891 | ||
Plasmodium chabaudi and Plasmodium vinckei: phagocytic activity of mouse reticuloendothelial system | Q47961467 | ||
Plasmodium gallinaceum: Chicken erythrocyte survival as determined by sodium radiochromate51 and di-isopropylfluorophosphate32 labeling | Q47961477 | ||
Suppression of autoimmune disease in NZB and (NZB x NZW) F1 hybrid mice by infection with malaria | Q47962396 | ||
Malaria resistance: artificial induction with a partially purified plasmodial fraction | Q47962485 | ||
Serological changes during the acquisition of immunity toPlasmodium vinckeiin mice | Q47963151 | ||
Plasmodium berghe: Phagocytic hyperactivity of infected rats | Q47963381 | ||
Immunity to malaria. I. Protection against Plasmodium knowlesi shown by monkeys sensitized with drug-suppressed infections or by dead parasites in Freund's adjuvant | Q47963395 | ||
Immunity to malaria. 3. Possible occurrence of a cell-mediated immunity to Plasmodium knowlesi in chronically infected and Freund's complete adjuvant-sensitized monkeys | Q47963404 | ||
The effect of reticulocytosis on Plasmodium vinckei infection in white mice. Action of phenylhydrazine and of repeated bleedings | Q47963894 | ||
A filterable, proliferating factor simulating autoimmunity in malarious and nonmalarious ducklings | Q47965696 | ||
Variants of Plasmodium berghei resistant to passive transfer of immune serum | Q47965702 | ||
Model system for study of artificially induced resistance to malaria | Q47967635 | ||
Exotoxin in malaria infection (Plasmodium berghei) | Q47970887 | ||
Immunogenic properties of serum antigens from chickens acutely infected withPlasmodium gallinaceum | Q47971323 | ||
The effect of splenectomy on the course of Plasmodium berghei infections in Microtus guentheri | Q47977857 | ||
Plasmodium berghei: Passive transfer of immunity by antisera and cells | Q50240410 | ||
Immune complexes in the nephrotic syndrome of African children. | Q50726798 | ||
Serological Studies on Nephrotic Syndrome of Quartan Malaria in Uganda | Q54061108 | ||
Immunological studies in tropical splenomegaly syndrome in Uganda | Q54066633 | ||
Enzyme variation in Plasmodium berghei and Plasmodium vinckei. | Q54145194 | ||
Nephrotic Syndrome in Monkey Infected with Human Quartan Malaria | Q55383316 | ||
Tropical Splenomegaly Syndrome: Long-term Proguanil Therapy Correlated with Spleen Size, Serum IgM, and Lymphocyte Transformation | Q55421514 | ||
Immunopathology of nephritis in Africa | Q56960818 | ||
Specificity of Protective Immunity produced by X-irradiated Plasmodium berghei Sporozoites | Q59071234 | ||
Mechanisms of immunity to malaria | Q36786560 | ||
A procedure for the harvesting of mammalian plasmodia | Q36910639 | ||
Anaemia in African trypanosomiasis and 'big spleen disease' in Uganda | Q38894931 | ||
Ultrastructure of the hepatic sinusoids in the tropical splenomegaly syndrome | Q38894955 | ||
Malarial antibodies and autoantibodies to heart and other tissues in the immigrant and indigenous peoples of Uganda | Q38897032 | ||
Malaria and the tropical splenomegaly syndrome in New Guinea | Q38955909 | ||
Immunological studies in tropical splenomegaly syndrome | Q39586392 | ||
Mechanisms involved in anaemia associated with infection and splenomegaly in the tropics | Q39602349 | ||
Immunology of malarial infection and its possible consequences | Q39868052 | ||
Malaria: Seroepidemiology and serologic diagnosis | Q39913667 | ||
The Research and Development of Serologic Tests for Malaria | Q39918253 | ||
The immunologic response to plasmodium. | Q39918258 | ||
Sporozoite-induced immunity in mammalian malaria. A review. | Q39918262 | ||
Serum-soluble antigens of malaria: a review | Q39955436 | ||
Current state of serological tests used to detect blood parasite infections | Q39955442 | ||
Symposium. The role of serum antibodies in malarial immunity. The detection and measurement of malarial antibodies | Q39999522 | ||
Serum antibody in acquired malarial immunity | Q39999529 | ||
Seroepidemiology of malaria | Q40014431 | ||
Use of Stable Sensitized Cells in an Improved Indirect Microhemagglutination Test for Malaria | Q40914703 | ||
Immunity to exoerythrocytic forms of malaria. II. Passive transfer of immunity to exoerythrocytic forms | Q41933825 | ||
Protective heterologous immunity between Plasmodium atheruri and other Plasmodium spp. and Babesia spp. in mice | Q41935130 | ||
Murine malaria. IV. Disturbed immunological responsiveness during Plasmodium berghei infection | Q41936529 | ||
Resistance to superinfection withPlasmodium bergheiin mice in which the original infection was suppressed by a milk diet | Q41937462 | ||
Immunological studies with simian malarias. II. Heterologous immunity in the "cynomolgi" group | Q41939651 | ||
Immunological studies with simian malarias I. Antigenic variants of Plasmodium cynomolgi bastianellii | Q41939664 | ||
Parasitemia and erythrocyte destruction in Plasmodium berghei-infected rats. II. Effect of infected host globulin | Q41939917 | ||
Coombs'-positive hemolytic disease in malaria | Q41940722 | ||
Can parasitic infection suppress autoimmune disease? | Q42938910 | ||
Plasmodium berghei: mechanisms and sites of resistance to sporogonic development in different mosquitoes | Q42995057 | ||
Plasmodium gallinaceum: Selective immunosuppression by cyclophosphamide in preerythrocytic malaria | Q42997167 | ||
Plasmodium gallinaceum: Effects of various compounds on immunity of susceptible Aedes aegypti and refractory Culex pipiens pipiens | Q42997834 | ||
Culex pipiens and Aedes aegypti: whole body extracts and development of Plasmodium gallinaceum in Aedes aegypti | Q43000024 | ||
Selectivity of proteinuria and response to prednisolone or immunosuppressive drugs in children with malarial nephrosis | Q43462029 | ||
Plasmodium berghei: detection in organs of infected mice by means of immunofluorescence | Q43564792 | ||
Effect of concurrent malarial infection on development of virus-induced lymphoma in Balb-c mice | Q43586263 | ||
Malaria: host-defense mechanisms and complications | Q43639545 | ||
Immunosuppression in children with malaria | Q43687771 | ||
The interaction of P. bergheii yoelii infection in mice with murine oncogenic viruses | Q43698713 | ||
Exogenous Interferon protects Mice against Plasmodium berghei Malaria | Q43769782 | ||
Immunosuppression in malaria | Q43809864 | ||
Immunity to malaria. II. Serological response of monkeys sensitized by drug-suppressed infection or by dead parasitized cells in Freund's complete adjuvant | Q43811604 | ||
Plasmodium berghei Infections in Thymectomized Rats | Q43812881 | ||
Malaria in the Pare area of Tanzania. IV. Malaria in the human population 11 years after the suspension of residual insecticide spraying, with special reference to the serological findings | Q43960389 | ||
Lipid content of Plasmodium berghei-infected rat red blood cells | Q44153336 | ||
Immunogenicity and infectivity of sporozoites of mammalian malaria isolated by density-gradient centrifugation | Q44154690 | ||
Plasmodium berghei: Relationship between protective immunity and anti-sporozoite (CSP) antibody in mice | Q44157746 | ||
Strain specific immunity to Plasmodium berghei: a new genetic marker | Q44157795 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | protozoa | Q101274 |
immunology | Q101929 | ||
P304 | page(s) | 473-446 | |
P577 | publication date | 1977-08-01 | |
P1433 | published in | Experimental Parasitology | Q15754029 |
P1476 | title | Current status of the immunology of blood and tissue protozoa | |
Current status of the immunology of blood and tissue protozoa. II. Plasmodium | |||
P478 | volume | 42 |